Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C.

International journal of medical sciences - 1 Jan 2017

Yamagiwa Satoshi, Ishikawa Toru, Waguri Nobuo, Sugitani Soichi, Kamimura Kenya, Tsuchiya Atsunori, Takamura Masaaki, Kawai Hirokazu, Terai Shuji

Abstract excerpt

Objectives: To determine whether the soluble programmed cell death ligand 1 (sPD-L1) levels in patients with chronic hepatitis C (CHC) are associated with the clinical features of the disease and the efficacy of treatment, including interferon (IFN)-α. Methods: We investigated the sPD-L1 levels in the sera of 80 genotype 1b Japanese patients with CHC who underwent 12 weeks of telaprevir (TVR)- or simeprevir...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Carcinoma, Hepatocellular

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepatitis C, Chronic

Share to Interferon-gamma

Share to Oligopeptides

Share to Ribavirin

Share to Simeprevir

Source

Open in PubMed Open full text

Identifiers

PMID: 28539815
DOI: 10.7150/ijms.18784
PMCID: PMC5441031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C.PMID 28539815Read ↗

Circulating level of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progression.Semantic proximity Read ↗

Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.Semantic proximity Read ↗

Plasma levels of sPD-1 and PD-1 genetic variants are associated with hepatitis B infection and related liver disease progressionSemantic proximity Read ↗

A Programmed Cell Death-1 Haplotype is Associated with Clearance of Hepatitis B Virus.Semantic proximity Read ↗

[Association of circulating levels of soluble PD-1, PD-1 gene polymorphisms with HBV infection and HBV infection-associated hepatocellular carcinoma].Semantic proximity Read ↗

PD-1 mRNA expression is associated with clinical and viral profile and PD1 3'-untranslated region polymorphism in patients with chronic HBV infection.Semantic proximity Read ↗

PD-1 expression on CTL may be related to more severe liver damage in CHB patients with HBV genotype C than in those with genotype B infection.Semantic proximity Read ↗

PD-1/PD-L1 signal pathway participates in HCV F protein-induced T cell dysfunction in chronic HCV infection.Semantic proximity Read ↗

Phenotypic Characteristics of PD-1 and CTLA-4 Expression in Symptomatic Acute Hepatitis A.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.